Bafna Pharmaceuticals informs about change in CS cum CO

21 Mar 2022 Evaluate

Bafna Pharmaceuticals has informed that Jitendra Kumar Pal ceases to be Company Secretary (CS) & Compliance officer (CO) of the Company with effect from closing of business hours of 21st March 2022. Appointment of Roopa Ravi Kumar as Company Secretary & Compliance officer of the Company with effect from 22nd March 2022 pursuant to section 203 of the Companies Act 2013 and Regulation 6(1) of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Bafna Pharma Share Price

164.20 -7.80 (-4.53%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×